730 related articles for article (PubMed ID: 12487785)
1. Glanzmann's thrombasthenia: updated.
Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
[TBL] [Abstract][Full Text] [Related]
2. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
[TBL] [Abstract][Full Text] [Related]
3. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
Perutelli P; Mori PG
Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
[TBL] [Abstract][Full Text] [Related]
4. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
Di Minno G; Coppola A; Di Minno MN; Poon MC
Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
[TBL] [Abstract][Full Text] [Related]
5. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and molecular basis of Glanzmann's thrombasthenia.
Perutelli P; Mori PG
Haematologica; 1992; 77(5):421-6. PubMed ID: 1483593
[TBL] [Abstract][Full Text] [Related]
7. Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type I.
Vannier C; Behnisch W; Bartsch I; Sandrock K; Ertle F; Schmidt K; Busse A; Superti-Furga A; Kulozik A; Santoso S; Zieger B
Klin Padiatr; 2010 May; 222(3):150-3. PubMed ID: 20514618
[TBL] [Abstract][Full Text] [Related]
8. Glanzmann's thrombasthenia: an overview.
Kannan M; Saxena R
Clin Appl Thromb Hemost; 2009; 15(2):152-65. PubMed ID: 18930954
[TBL] [Abstract][Full Text] [Related]
9. A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry.
Giannini S; Mezzasoma AM; Guglielmini G; Rossi R; Falcinelli E; Gresele P
Cytometry B Clin Cytom; 2008 May; 74(3):194-9. PubMed ID: 18200593
[TBL] [Abstract][Full Text] [Related]
10. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
[TBL] [Abstract][Full Text] [Related]
11. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL
Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422
[TBL] [Abstract][Full Text] [Related]
12. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
Léticée N; Kaplan C; Lémery D
Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
[TBL] [Abstract][Full Text] [Related]
14. Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder.
Tholouli E; Hay CR; O'Gorman P; Makris M
Br J Haematol; 2004 Oct; 127(2):209-13. PubMed ID: 15461628
[TBL] [Abstract][Full Text] [Related]
15. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases.
Porcelijn L; Huiskes E; Maatman R; de Kreuk A; de Haas M
Vox Sang; 2008 Nov; 95(4):324-30. PubMed ID: 19138263
[TBL] [Abstract][Full Text] [Related]
16. PMA induces platelet activation of specific antigens (CD62/CD63) in GpIIb-IIIa deficient platelets from Glanzmann's thrombasthenia.
Baudouin-Brignole F; Bayle J; Goguel A; Philip PJ
Platelets; 1997; 8(6):391-5. PubMed ID: 16793673
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the GPIIb and GPIIIa genes in patients with Glanzmann's thrombasthenia].
Yasunaga M; Ryo R; Adachi M; Sugano W; Yoshida A; Nakayama K; Saigo K; Yasunaga K; Yamaguchi N
Rinsho Ketsueki; 1992 Feb; 33(2):133-8. PubMed ID: 1635160
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum of Glanzmann's thrombasthenia.
Badhe BA; Jayanthi S; Datta T
Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
[TBL] [Abstract][Full Text] [Related]
19. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
[TBL] [Abstract][Full Text] [Related]
20. Homozygous Cys542-->Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann's thrombasthenia.
Ruan J; Schmugge M; Clemetson KJ; Cazes E; Combrie R; Bourre F; Nurden AT
Br J Haematol; 1999 May; 105(2):523-31. PubMed ID: 10233432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
